paclitaxel has been researched along with Complication, Postoperative in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.99) | 18.2507 |
| 2000's | 45 (33.58) | 29.6817 |
| 2010's | 70 (52.24) | 24.3611 |
| 2020's | 15 (11.19) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, GH; Choi, ST; Jung, J; Kang, JM; Ko, DS | 1 |
| Anand, SS; Bauersachs, RM; Beckman, JA; Berkowitz, SD; Bonaca, MP; Brackin, T; Capell, WH; Debus, ES; Fanelli, F; Govsyeyev, N; Haskell, LP; Hess, CN; Hiatt, WR; Mauri, L; Muehlhofer, E; Nehler, MR; Patel, MR; Secemsky, EA; Yeh, RW | 1 |
| Liu, H; Long, Y; Lyu, X; Ma, D; Qin, Y; Shi, J; Tang, B; Wang, M; Xu, Y | 1 |
| Chen, L; Cui, M; Liu, M; Su, X; Tan, F; Wu, B; Xing, J; Xu, K; Yang, H; Yao, Z; Zhang, C; Zhang, N | 1 |
| Funatsu, A; Kobayashi, T; Mizobuchi, M; Nagai, T; Nakamura, S | 1 |
| Bennink, RJ; Biermann, K; Doukas, M; Gisbertz, SS; Krishnadath, KK; Lagarde, SM; Luyer, M; Meijer, SL; Neijenhuis, LKA; Nieboer, D; Nieuwenhuijzen, GAP; Nikkessen, S; Noordman, BJ; Oostenbrug, LE; Riedl, RG; Roef, MJ; Schoon, EJ; Sosef, MN; Spaander, MCW; Valkema, R; van Berge Henegouwen, MI; van der Gaast, A; van der Wilk, BJ; van Lanschot, JJB; van Lijnschoten, I; Wijnhoven, BPL | 1 |
| Kaneuchi, M; Kobayashi, Y; Machida, H; Matsumura, N; Matsuo, K; Mikami, M; Nagase, S; Tabata, T; Tokunaga, H | 1 |
| Kee, TYS; Liew, ZH; Lim, CC; Loh, AHL; Tan, CS | 1 |
| Eoh, KJ; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, J | 1 |
| Karmota, AG | 1 |
| Bhak, Y; Choi, BJ; Garg, S; Hao, J; Hui, L; Jun, EJ; Kim, TH; Kun, L; Qiang, T; Shin, ES; Sohn, CB; Yuan, SL; Zhentao, S; Zhi, W | 1 |
| Chen, J; Cui, T; Jin, Q; Li, H; Shi, Y; Wu, K; Yan, Y; Yin, Y; Yu, Z; Zhang, L | 1 |
| Chen, C; Chen, KN; Dai, L; Du, M; Fang, Y; Gong, L; Hou, Y; Jiang, H; Jiao, J; Li, H; Li, K; Li, W; Li, Z; Lian, C; Liao, Y; Liu, J; Shen, Y; Tan, L; Tang, H; Wang, H; Wu, H; Xie, D; Yin, J; Zeng, Z; Zhao, Q; Zheng, B; Zhu, J | 1 |
| Cooper, L; De León, LE; Dezube, AR; Dumontier, C; Enzinger, P; Frain, LN; Jaklitsch, MT; Kucukak, S; Mamon, H; Mazzola, E; Wee, JO | 1 |
| Anderson, MA; Chadban, S; Ferguson, PM; Gracey, DM; Grimison, P; Strach, MC; Wyburn, K; Ying, T | 1 |
| Dawkins, KD; Head, SJ; Holmes, DR; Kappetein, AP; Mack, MJ; Milojevic, M; Mohr, FW; Morice, MC; Serruys, PW | 1 |
| Bellone, P; Benfari, G; Botta, M; Cordone, S; Cuman, M; Fede, A; Ghione, M; Lunardi, M; Pacchioni, A; Reimers, B; Ribichini, FL; Zivelonghi, C | 1 |
| Bednarski, K; Bil, J; Bojko, K; Gil, RJ; Górny, J; Kern, A; Rzeszowski, B | 1 |
| Ancrile, BB; Birkholz, JH; Blandford, JT; Dye, CE; Gusani, NJ; Headlee, BD; Heisey, HD; Levenick, JM; Maranki, JL; Mathew, A; McGarrity, TJ; Moyer, MT; Sharzehi, S | 1 |
| Chang, S; Choi, BW; Han, K; Hong, YJ; Hur, J; Im, DJ; Kim, JY; Kim, YJ; Lee, HJ; Suh, YJ | 1 |
| Balouet, S; Dupin, J; Ghazi, Y; Joly, F; Laurent, C; Menguy, V; Pau, D; Rocha, Y; Rouzier, R | 1 |
| Hendriksen, EM; Hoekstra, R; Kouwenhoven, EA; Kreuger, MJ; Lubbers, M; van Det, MJ; Vermeer, M | 1 |
| Autorino, R; Cosentino, F; Ferrandina, G; Gallotta, V; Gambacorta, MA; Gui, B; Macchia, G; Mattoli, MV; Palluzzi, E; Ronzino, G; Scambia, G; Turco, LC; Valentini, V | 1 |
| Kruitwagen, RF; Lalisang, RI; Sonke, GS; Timmermans, M; Van de Vijver, KK; van der Aa, MA; Witteveen, PO | 1 |
| Lawson, J; Roy-Chaudhury, P; Saad, TF; Trerotola, SO | 1 |
| Ji, F; Lu, D; Wang, F; Wang, X; Xu, F; Yang, C; Yu, X; Zhang, W | 1 |
| Cheng, Y; Liu, F; Liu, X; Ma, X; Sun, Y; Zhang, D; Zhao, Y; Zhou, Y | 1 |
| Adsay, V; Attila, T; Faigel, DO | 1 |
| Collins, N; Elisofon, SA; Fawaz, R; Lee, CK; Ocwieja, KE; Sharma, TS; Shulman, DS; Vakili, K; Vargas, SO | 1 |
| Cheng, RW; Chong, TT; Foo, WY; Gogna, A; Kho, YX; Pang, SC; Phang, CC; Tan, CS; Tan, CW; Tan, RY; Teh, SP | 1 |
| Deng, LX; Guo, WY; Hu, T; Li, JY; Li, Y; Liu, Y; Mou, FJ; Tao, L; Wang, Q; Yin, ZY; Zhang, YJ | 1 |
| Baratti, D; Deraco, M; Guaglio, M; Kusamura, S; Nizri, E; Rajendra, VJ; Salcedo-Hernández, RA; Sinukumar, S | 1 |
| Doyle, SL; Elliott, JA; Foley, G; Guinan, EM; King, S; Murphy, CF; O'Byrne, L; Ravi, N; Reynolds, JV | 1 |
| Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Ishibashi, K; Kashiwagi, M; Kitabata, H; Komukai, K; Kubo, T; Mizukoshi, M; Takarada, S; Takemoto, K; Tanaka, A; Tanimoto, T | 1 |
| Bourantas, C; Garg, S; Serruys, PW | 1 |
| Carlino, M; Chieffo, A; Colombo, A; Costopoulos, C; Figini, F; Giannini, F; Kawaguchi, M; Latib, A; Montorfano, M; Naganuma, T; Naim, C; Sticchi, A | 1 |
| Fu, JH; Gao, Z; Ren, CC; Shi, YG | 1 |
| Badr, S; Barbash, IM; Chen, F; Dvir, D; Kent, KM; Kitabata, H; Loh, JP; Minha, S; Pendyala, LK; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R | 1 |
| Chéreau, E; Houvenaeghel, G; Lambaudie, E | 1 |
| Aoki, D; Banno, K; Katakura, S; Kisu, I; Nogami, Y; Tominaga, E; Tsuji, K; Umene, K | 1 |
| Beukema, JC; Bosch, DJ; Burgerhof, JG; Hospers, GA; Muijs, CT; Mul, VE; Plukker, JT | 1 |
| Inoue, K; Inoue, M; Kanaya, H; Matsubara, T; Miwa, K; Yasuda, T | 1 |
| Badr, S; Barbash, IM; Ben-Dor, I; Loh, JP; Minha, S; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
| Bangalore, S; Feit, F; Toklu, B | 1 |
| Hirano, K; Ishibashi, Y; Ishimori, H; Ito, Y; Muramatsu, T; Nakano, M; Nakatani, S; Onuma, Y; Tsukahara, R; Yamawaki, M | 1 |
| Arjona-Sánchez, A; Briceño Delgado, J; Casado-Adam, A; Garcilazo Arismendi, DJ; Gómez-Luque, I; Medina Fernández, FJ; Muñoz-Casares, FC; Rufián Peña, S; Thoelecke, H | 1 |
| Chae, IH; Cho, GY; Cho, YS; Choi, DJ; Lee, S; Oh, IY; Suh, JW; Yoon, CH; Youn, TJ | 1 |
| Brodie, BR; Duffy, PL; Kang, SJ; Kirtane, AJ; Maehara, A; Metzger, DC; Mintz, GS; Rinaldi, MJ; Shimizu, T; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K | 1 |
| Brener, SJ; Brodie, BR; Ertelt, K; Genereux, P; Guagliumi, G; Mehran, R; Stone, GW; Witzenbichler, B; Xu, K | 1 |
| Hurkmans, CW; Koëter, M; Luyer, MD; Nieuwenhuijzen, GA; Rutten, HJ; van der Sangen, MJ | 1 |
| Aziz, AB; Chishti, U | 1 |
| Khosla, S; Malhotra, G; Sethi, A; Singh, PP; Singh, S | 1 |
| Cox, D; Lasala, J; Lee, MS; Yang, T | 1 |
| Costa, VP; Freitas, FR; Lima, PP; Maranhão, RC; Occhiutto, ML | 1 |
| Ishikawa, T; Miyamoto, T; Mutoh, M; Nakano, Y | 1 |
| Chiantera, V; Cosentino, F; Costantini, B; Fagotti, A; Fanfani, F; Ferrandina, G; Gallotta, V; Gueli Alletti, S; Margariti, PA; Scambia, G; Tortorella, L; Vizzielli, G | 1 |
| Egami, Y; Makino, N; Mori, N; Nishino, M; Okamoto, N; Sakata, Y; Shutta, R; Tanaka, A; Tanouchi, J; Yano, M | 1 |
| Dobrodeev, AY; Tuzikov, SA; Zav'yalov, AA | 1 |
| Creemers, GJ; Kathiravetpillai, N; Koëter, M; Luyer, MD; Nieuwenhuijzen, GA; Rutten, HJ; van der Sangen, MJ | 1 |
| Eccleshall, S; Ho, HH; Mok, KH; Ong, PJL; Watson, T; Wickramarachchi, U | 1 |
| Ataseven, B; du Bois, A; Harter, P; Heitz, F; Hengsbach, A; Kurzeder, C; Prader, S; Schneider, S; Sporkmann, M; Traut, A | 1 |
| Qiu, XJ; Wang, J; Wang, YL; Xu, M; Zhang, J | 1 |
| Aminossadati, B; duBois, A; Fotopoulou, C; Karavas, AN; Pfisterer, J; Schmalfeldt, B; Sehouli, J; Trappe, R | 1 |
| Choung, HK; Hwang, JM; Jin, SE; Kim, CK; Lee, MJ | 1 |
| Boersma, E; Daemen, J; Hellige, G; Jüni, P; Kukreja, N; Meier, B; Morger, C; Serruys, PW; Tsuchida, K; Vaina, S; van Domburg, R; Wenaweser, P; Windecker, S; Zwahlen, M | 1 |
| Legrand, V; Nyssen, A; Scheen, AJ | 1 |
| Baim, DS; Deshpande, MC; Kandzari, DE; Malik, AZ; Maloney, TH; Mayor, M; Minor, RJ; O'Neill, W; Strauss, WE | 1 |
| Bedor, M; Burrows, W; Edelman, MJ; Krasna, MJ; Smith, R; Suntharalingam, M | 1 |
| Bryant, AS; Cerfolio, RJ; Talati, A | 1 |
| Basu, S; Faber, LP; Kim, AW; Liptay, MJ; Miller, C; Milman, S; Warren, WH | 1 |
| Lazzati, V; Lohsiriwat, V; Petit, JY; Veronesi, P; Zygoń, J | 1 |
| Allocco, DJ; Aprile, A; Bezerra, HG; Costa, MA; Dawkins, KD; Fiocca, L; Guagliumi, G; Kyono, H; Lortkipanidze, N; Matiashvili, A; Musumeci, G; Popma, JJ; Sirbu, V; Valsecchi, O; Vassileva, A | 1 |
| Abelson, M; Brown, B; Conway, D; Hellig, F; Hirata, K; Khan, S; Kozuki, A; Miyoshi, N; Mpe, M; Ntsekhe, M; Sawada, T; Shinke, T; Shite, J | 1 |
| Bongo, AS; Buffon, A; De Servi, S; Lazzero, M; Lupi, A; Navarese, EP; Sansa, M; Serra, A | 1 |
| Michishita, I | 1 |
| Altay, H; Binici, S; Ciçek, D; Haberal, C; Kalay, N; Müderrisoğlu, H; Pekdemir, H | 1 |
| Bowman, TS; Cox, DA; Dawkins, KD; Huang, PH; Lasala, JM; Starzyk, RM; Yeung, M | 1 |
| Hoshi, T; Tanaka, M; Yoshimatsu, A | 1 |
| Applegate, RJ; Cohen, DJ; Gandhi, SK; Kutcher, MA; Little, WC; Sacrinty, MT; Santos, RM; Schafer, PE | 1 |
| Imamoto, H; Imano, M; Itoh, T; Kato, H; Okuno, K; Peng, YF; Satou, T; Shinkai, M; Shiozaki, H; Shiraishi, O; Takeyama, Y; Yasuda, A; Yasuda, T | 1 |
| Endo, D; Hosaka, M; Kato, T; Kikawa, S; Konno, Y; Mitamura, T; Odagiri, T; Sakuragi, N; Suzuki, Y; Watari, H | 1 |
| Jiang, G; Li, J; Li, X; Li, Y; Liu, J; Wang, J; Yang, F; Zhao, H | 1 |
| Bae, JH; Hur, SH; Jang, Y; Jeong, MH; Kim, HS; Park, JS; Park, K; Park, KW; Rha, SW; Yoon, JH | 1 |
| Brodie, B; Cristea, E; Dressler, O; Guagliumi, G; Guo, N; Kubo, T; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Witzenbichler, B; Wu, X; Xu, K; Yang, J | 1 |
| Applegate, RJ; Cao, S; Cutlip, DE; Hattori, K; Hermiller, JB; Hou, L; Kereiakes, DJ; Pervaiz, MH; Sood, P; Stone, GW; Su, X; Sudhir, K; Wang, J; Yaqub, M | 1 |
| Desale, S; Ellis, SG; Grube, E; Laynez-Carnicero, A; Mintz, GS; Ormiston, JA; Pakala, R; Pichard, AD; Romaguera, R; Sardi, G; Stone, GW; Turco, MA; Wakabayashi, K; Waksman, R; Weissman, NJ; Xue, Z | 1 |
| White, HD | 1 |
| Cosio, S; Fuso, L; Gadducci, A; Landoni, F; Maggino, T; Sartori, E; Zola, P | 1 |
| Antoniucci, D; Carrabba, N; Dovellini, EV; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
| Avsar, Y; Beckebaum, S; Cicinnati, VR; Cordesmeyer, S; Kabar, I; Reinecke, H; Schmidt, HH | 1 |
| Brodie, BR; Chantziara, V; Claessen, BE; Dangas, GD; Guagliumi, G; Henriques, JP; Kikkert, WJ; Mehran, R; Sanidas, EA; Stone, GW; Tijssen, JG; Witkowski, A; Witzenbichler, B; Wöhrle, J; Xu, K; Zmudka, K | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kozuki, A; Matsumoto, D; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Sierra, A; Torre, W | 1 |
| Frank, E; Geissler, EK; Graeb, C; Iesalnieks, I; Jauch, KW; Scherer, MN; Tange, S | 1 |
| Bettini, AC; Cohen, D; Danenberg, P; Florentine, B; Formenti, SC; Gee, C; Groshen, S; Muggia, F; Perez, E; Press, M; Skinner, KA; Spicer, D; Volm, M | 1 |
| Bearden, JD; Gray, JR; Greco, FA; Hainsworth, JD; Houston, GA; Litchy, S; Shaffer, DW | 1 |
| Doyle, A; Edelman, MJ; Gamliel, Z; Hausner, P; Krasna, M; Patel, AB; Sonett, JR; Suntharalingam, M | 1 |
| Brady, MF; Clarke-Pearson, D; Moore, DH; Nerenstone, S; Olt, G; Rose, PG; Rubin, SC; Small, JM | 1 |
| Aujeský, R; Benes, P; Hajdúch, M; Havlík, R; Klein, J; Král, V; Neoral, C; Vrba, R | 1 |
| Bavry, AA; Bhatt, DL; Helton, TJ; Kumbhani, DJ | 1 |
| Aoki, J; de Feyter, P; de Jaegere, PP; Hoye, A; McFadden, EP; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Sonnenschein, K; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Escaned, J; Fernández, C; Fernández-Ortiz, A; Hernández, R; Macaya, C; Moreno, R; Sabaté, M | 1 |
| Airoldi, F; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; Ge, L; Iakovou, I; Melzi, G; Michev, I; Montorfano, M; Sangiorgi, GM | 1 |
| Bidziński, M; Danska-Bidzińska, A; Derlatka, P; Raczyński, P; Sobiczewski, P; Ziółkowska-Seta, I | 1 |
| Crepin, F; Decoene, C; Fabre, O; Pol, A; Vincentelli, A | 1 |
| Choong, CK; Cooper, JD; Haddad, FJ; Martinez, C; Massetti, P; Phan, L; Roschak, E | 1 |
| Beard, M; Cheng, JD; Freedman, G; Goldberg, M; Henry, LR; Konski, A; McLaughlin, S; Meropol, NJ; Scott, W; Watts, P; Weiner, LM | 1 |
| Airoldi, F; Aoki, J; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; de Feyter, PJ; Ge, L; Hoye, A; Iakovou, I; Michev, I; Montorfano, M; Ong, AT; Rodriguez Granillo, GA; Sangiorgi, GM; Serruys, PW; Sianos, G; Valgimigli, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
| Di Ciolla, F; Fineschi, M; Gori, T; Iadanza, A; Maccherini, M; Pierli, C; Tsioulpas, C | 1 |
| Daly, BD; Dipetrillo, TA; Fernando, HC; Kachnic, LA; Ketchedjian, A; Morelli, DM; Shemin, RJ | 1 |
| Abbrederis, K; Bassermann, F; Busch, R; Lordick, F; Peschel, C; Roethling, N; Schuhmacher, C; Sendler, A; Siewert, JR; Voelter, V | 1 |
| Bennett, DH; Brooks, NH; Kumar, S; Lee, HS; Levy, RD; Prendergast, BD; Ray, SG; Suresh, V; Wicks, P | 1 |
| Dehmer, GJ; McAllister, RK; Meyer, TA | 1 |
| Albaladejo, P; Lehot, JJ; Marcotte, G; Marret, E; Monier, F; Piriou, V; Samama, CM; Vichova, Z | 1 |
| Baz, JA; Bordes, P; de la Torre, JM; Hernandez, JM; Iñiguez, A; Lozano, I; Mainar, V; Mauri, J; Sanmartin, M | 1 |
| Cocchia, R; Cook, S; Hess, OM; Meier, B; Räber, L; Togni, M; Wenaweser, P; Windecker, S | 1 |
| Alvarez, J; Campaña, O; Lamas, M; Lorenzo, D; Pérez, J; Rodríguez, MJ; Veiras, S | 1 |
| Ballert, NM; Baum, VC; de Souza, DG | 1 |
| Baron, DW; Faddy, SC; Muller, DW; Roy, PR; Ruchin, PE; Wilson, SH | 1 |
| Banerjee, S; Berger, PB; Brilakis, ES | 1 |
| Cardoso, PF; Eng, P; Hopkins, P; Ng, AW; Snell, GI; Stamatis, G; Sybrecht, GW | 1 |
| Baik, SK; Kim, HG; Kim, HS; Kim, JW; Lee, DH; Lee, DK; Lee, SJ; Oh, SJ; Suk, KT; Won, YH | 1 |
| Maxwell, GL; McGuire, WP; Muggia, F; Rose, GS; Rose, PG; Rubin, SC; Sundborg, MJ; Tian, C; Winter, WE | 1 |
| Colombo, A; Latib, A | 1 |
| Bonomi, P; Faber, LP; LaFollette, S; Lincoln, S; Recine, D; Sharma, M; Warren, W | 1 |
| Akerley, W; Chougule, P; Koness, RJ; Leone, L; McRae, R; Nigri, P; Ready, N; Safran, H; Wanebo, HJ; Webber, B | 1 |
| Grondin, SC; Sugarbaker, DJ | 1 |
| Corso, F; Florentine, B; Formenti, SC; Lomis, TJ; Silberman, H; Skinner, KA; Spicer, D | 1 |
| Eisenberger, MA; Laufer, M; Schoenberg, MP | 1 |
| Carbone, D; Choy, H; Devore, R; Eustis, C; Johnson, D; Roberts, JR | 1 |
| Hiraga, K; Honda, O; Matsuo, K | 1 |
| Florack, G; Graeff, H; Kuhn, W; Pachyn, D; Rutke, S; Schmalfeldt, B; Späthe, K; Ulm, K; von Hundelshausen, B | 1 |
| Burgess, L; Burt, HM; Hunter, WL; Jackson, JK; Skinner, KC; Sun, T | 1 |
| Jampel, HD; Koya, P; Leong, K; Quigley, HA | 1 |
10 review(s) available for paclitaxel and Complication, Postoperative
| Article | Year |
|---|---|
Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Mortality; Neoadjuvant Therapy; Odds Ratio; Ovarian Neoplasms; Paclitaxel; Perioperative Period; Postoperative Complications; Proportional Hazards Models; Randomized Controlled Trials as Topic; Tumor Burden | 2020 |
The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: a systematic review.
Topics: Ablation Techniques; Adult; Aged; Endosonography; Ethanol; Female; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Cyst; Postoperative Complications; Predictive Value of Tests; Risk Factors; Treatment Outcome | 2019 |
DES the year in review: controversies.
Topics: Biocompatible Materials; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Diabetes Complications; Disease-Free Survival; Drug-Eluting Stents; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Postoperative Complications; Sirolimus; Thrombolytic Therapy; Treatment Outcome | 2013 |
Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
Topics: Coronary Artery Bypass; Diabetes Complications; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Humans; Intention to Treat Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Randomized Controlled Trials as Topic; Reoperation; Sirolimus; Stroke; Survival Analysis; Treatment Outcome | 2014 |
Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.
Topics: Angioplasty, Balloon; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sirolimus | 2015 |
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients.
Topics: Aged; Aged, 80 and over; Angioplasty; Bias; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Regression Analysis; Saphenous Vein; Sirolimus; Stents; Treatment Outcome | 2011 |
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Length of Stay; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pancoast Syndrome; Pneumonectomy; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2005 |
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Follow-Up Studies; Humans; Paclitaxel; Postoperative Complications; Risk Factors; Sirolimus; Statistics as Topic; Stents; Treatment Outcome | 2005 |
The risk of drug-eluting stent thrombosis with noncardiac surgery.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Coated Materials, Biocompatible; Coronary Disease; Endothelium, Vascular; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Surgical Procedures, Operative; Time Factors | 2007 |
35 trial(s) available for paclitaxel and Complication, Postoperative
| Article | Year |
|---|---|
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Topics: Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Chronic Limb-Threatening Ischemia; Drug-Eluting Stents; Endovascular Procedures; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Paclitaxel; Peripheral Arterial Disease; Postoperative Complications; Proportional Hazards Models | 2021 |
Paclitaxel coated-balloon (PCB) versus standard plain old balloon (POB) fistuloplasty for failing dialysis access.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Coated Materials, Biocompatible; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Renal Dialysis; Vascular Access Devices; Vascular Diseases | 2020 |
Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial.
Topics: Adult; Aged; Angioplasty, Balloon; Arteriovenous Shunt, Surgical; Coated Materials, Biocompatible; Constriction, Pathologic; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Renal Dialysis; Treatment Outcome; Vascular Patency | 2021 |
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Intention to Treat Analysis; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Postoperative Complications; Prospective Studies; Quality of Life; Survival Rate; Thoracoscopy | 2021 |
Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Practice Patterns, Physicians'; Quality Improvement; Time Factors; United States | 2017 |
The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol.
Topics: Ablation Techniques; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Double-Blind Method; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Ethanol; Female; Gemcitabine; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Cystic, Mucinous, and Serous; Paclitaxel; Pancreatic Cyst; Pancreatic Neoplasms; Pennsylvania; Postoperative Complications; Prospective Studies; Risk Factors; Therapeutic Irrigation; Time Factors; Treatment Outcome | 2017 |
A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bevacizumab; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Research Design | 2018 |
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Intention to Treat Analysis; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvis; Postoperative Complications; Radiotherapy, Intensity-Modulated; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial.
Topics: Angioplasty, Balloon; Arteriovenous Shunt, Surgical; Coated Materials, Biocompatible; Constriction, Pathologic; Drug Carriers; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Time Factors; Treatment Outcome | 2018 |
Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carboplatin; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications; Preoperative Care; Quality of Life; Respiration Disorders; Vital Capacity | 2019 |
Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents.
Topics: Aged; Blood Vessel Prosthesis Implantation; Body Mass Index; Comorbidity; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Obesity; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional; United States | 2015 |
Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Antithrombins; Coronary Angiography; Coronary Restenosis; Disease Progression; Drug-Eluting Stents; Electrocardiography; Female; Hemorrhage; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prognosis; Recombinant Proteins; Reoperation | 2015 |
Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
Topics: Aftercare; Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; United States; Vascular Calcification | 2016 |
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Body Image; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Length of Stay; Middle Aged; Neoplasms, Glandular and Epithelial; Operative Time; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Quality of Life; Young Adult | 2016 |
One-year outcomes from the TAXUS express stent versus cypher stent.
Topics: Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; United States | 2009 |
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Early Termination of Clinical Trials; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Protease Inhibitors; Pyrazines; Radiotherapy; Respiratory Insufficiency | 2010 |
Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).
Topics: Absorbable Implants; Aged; Angioplasty; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Pilot Projects; Polymers; Postoperative Complications; Tomography, Optical Coherence; Ultrasonography, Interventional | 2010 |
STELLIUM 1: First-in-man follow-up evaluation of bioabsorbable polymer-coated paclitaxel-eluting stent.
Topics: Aged; Angina Pectoris; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Polymers; Postoperative Complications; Thrombosis; Treatment Outcome | 2010 |
Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Paclitaxel; Postoperative Complications; Treatment Outcome; Ultrasonography, Interventional | 2012 |
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Topics: Aged; Biomarkers; Blood Vessel Prosthesis Implantation; Creatine Kinase; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Practice Guidelines as Topic; Prognosis; Prospective Studies; Reference Standards; Sensitivity and Specificity; Sirolimus; Survival Analysis; Troponin; United States; United States Food and Drug Administration; World Health Organization | 2012 |
Impact of drug-eluting stents on distal vessels.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Ultrasonography, Interventional; Wound Healing | 2012 |
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.
Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Risk Factors; Treatment Outcome | 2013 |
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Feasibility Studies; Female; Humans; Mastectomy, Modified Radical; Middle Aged; Neoplasm Staging; Paclitaxel; Postoperative Care; Postoperative Complications; Preoperative Care; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome | 2003 |
A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Paclitaxel; Pneumonectomy; Postoperative Complications; Survival Rate; Thoracotomy; United States | 2004 |
Secondary surgical cytoreduction for advanced ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Survival Analysis | 2004 |
[What to expect from the neoadjuvant therapy of the oesophageal carcinoma?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Fluorouracil; Humans; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2005 |
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Postoperative Complications; Sirolimus; Stents; Survival Analysis; Time Factors; Treatment Outcome | 2005 |
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Follow-Up Studies; Humans; Paclitaxel; Postoperative Complications; Risk Factors; Sirolimus; Statistics as Topic; Stents; Treatment Outcome | 2005 |
Analysis of the treatment of ovarian cancer patients with neo-adjuvant chemotherapy--preliminary results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Treatment Outcome | 2005 |
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications; Radiotherapy Dosage; Remission Induction; Survival Rate | 2006 |
Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cisplatin; Combined Modality Therapy; Epoetin Alfa; Erythropoietin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Hemoglobins; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Postoperative Complications; Prospective Studies; Recombinant Proteins; Stomach Neoplasms; Survival Analysis | 2006 |
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Radiotherapy; Radiotherapy Dosage | 1997 |
Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Postoperative Complications; Preoperative Care; Prospective Studies; Survival Analysis; Treatment Outcome | 1999 |
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Prognosis; Survival Analysis; Treatment Outcome | 2001 |
91 other study(ies) available for paclitaxel and Complication, Postoperative
| Article | Year |
|---|---|
Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Comorbidity; Female; Humans; Leg; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Postoperative Complications; Stents | 2021 |
Multi-organs perioperative immune-related adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with NSCLC.
Topics: Bronchial Fistula; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Immunotherapy; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications | 2022 |
The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.
Topics: Humans; Neoadjuvant Therapy; Neoplasms, Second Primary; Paclitaxel; Postoperative Complications; Stomach Neoplasms | 2022 |
Acute and mid-term outcomes of drug-coated balloon following rotational atherectomy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome; Tubulin Modulators; Vascular Access Devices; Vascular Calcification | 2020 |
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
Topics: Adult; Aged; Carboplatin; Chemoradiotherapy; Endosonography; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Postoperative Complications; Propensity Score; Prospective Studies; Reoperation; Watchful Waiting | 2021 |
Paclitaxel embolism in a transplant kidney: a rare complication of drug-coated balloon angioplasty.
Topics: Angioplasty, Balloon; Coated Materials, Biocompatible; Embolism; Female; Humans; Kidney Transplantation; Paclitaxel; Postoperative Complications; Young Adult | 2020 |
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; CA-125 Antigen; Carboplatin; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment Outcome | 2020 |
Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dissection; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2020 |
Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Humans; Length of Stay; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Patient Compliance; Postoperative Complications; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Time Factors | 2021 |
Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Humans; Kidney Transplantation; Male; Paclitaxel; Penile Neoplasms; Postoperative Complications; Sarcoma, Kaposi | 2021 |
Drug-coated balloon: Long-term outcome from a real world three-center experience.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Postoperative Complications; Registries; Retrospective Studies; Treatment Outcome | 2017 |
Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Poland; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Survival Rate; Tissue Scaffolds; Treatment Outcome | 2018 |
SYNTAX score based on coronary computed tomography angiography may have a prognostic value in patients with complex coronary artery disease: An observational study from a retrospective cohort.
Topics: Aged; Cerebrovascular Disorders; Combined Modality Therapy; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Predictive Value of Tests; Prognosis; Retrospective Studies | 2017 |
Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Paclitaxel; Positron Emission Tomography Computed Tomography; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2018 |
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Fallopian Tube Neoplasms; Female; Humans; Length of Stay; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Postoperative Complications; Survival Rate; Time Factors | 2018 |
Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
Topics: Antineoplastic Agents, Phytogenic; China; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Hospitals, University; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8.
Topics: Biliary Atresia; Biopsy, Needle; Disease Progression; Female; Ganciclovir; Herpesvirus 8, Human; Humans; Immunosuppression Therapy; Infant; Liver; Liver Transplantation; Magnetic Resonance Imaging; Male; Paclitaxel; Postoperative Complications; Sarcoma, Kaposi; Tissue Donors | 2019 |
Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up.
Topics: Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arteriovenous Shunt, Surgical; Coated Materials, Biocompatible; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Paclitaxel; Postoperative Complications; Renal Dialysis; Reoperation; Thrombosis; Treatment Outcome; Vascular Access Devices; Vascular Grafting; Vascular Patency | 2019 |
12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm.
Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Equipment Design; Feasibility Studies; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institut
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytoreduction Surgical Procedures; Doxorubicin; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Length of Stay; Middle Aged; Neoadjuvant Therapy; Neoplasms, Cystic, Mucinous, and Serous; Paclitaxel; Peritoneal Neoplasms; Peritoneum; Postoperative Complications; Progression-Free Survival; Retrospective Studies | 2019 |
Clinical significance of low signal intensity area surrounding stent struts identified by optical coherence tomography.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Immunosuppressive Agents; Japan; Male; Middle Aged; Neointima; Outcome Assessment, Health Care; Paclitaxel; Postoperative Complications; Prospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Tubulin Modulators | 2013 |
Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits.
Topics: Aged; Antineoplastic Agents; Cause of Death; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prosthesis Design; Reoperation; Sirolimus; Veins | 2013 |
Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Complications; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vincristine | 2013 |
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome | 2013 |
Morbidity of surgery after neoadjuvant chemotherapy including bevacizumab for advanced ovarian cancer.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Female; Follow-Up Studies; Humans; Middle Aged; Morbidity; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Postoperative Complications; Prognosis | 2013 |
Case of streptococcal toxic shock syndrome caused by rapidly progressive group A hemolytic streptococcal infection during postoperative chemotherapy for cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Delayed Diagnosis; Disease Progression; Female; Humans; Hysterectomy; Immunocompromised Host; Omentum; Paclitaxel; Peritonitis; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carboplatin; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pneumonia; Postoperative Complications; Prognosis; Prospective Studies; Survival Rate; Thoracotomy | 2014 |
Comparison of sirolimus-eluting, paclitaxel-eluting, and bare-metal stents in a patient with angina pectoris: histopathological autopsy findings of the third month.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Autopsy; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Fatal Outcome; Humans; Male; Paclitaxel; Postoperative Complications; Sirolimus; Thrombosis; Treatment Outcome | 2014 |
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.
Topics: Aged; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Sirolimus; Treatment Outcome | 2014 |
Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.
Topics: Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Shock, Cardiogenic; Sirolimus; Treatment Outcome; Ultrasonography, Interventional | 2015 |
Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC.
Topics: Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Carboplatin; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Inflammation Mediators; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience .
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Republic of Korea; Sirolimus; Treatment Outcome; Vascular Patency | 2015 |
Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Postoperative Complications; Prognosis; Radiotherapy Dosage; Survival Rate | 2015 |
Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Carcinoma, Endometrioid; Cytoreduction Surgical Procedures; Disease-Free Survival; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Pakistan; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2015 |
Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cicatrix; Conjunctiva; Disease Models, Animal; Drug Carriers; Follow-Up Studies; Glaucoma; Injections; Intraocular Pressure; Lipids; Male; Nanoparticles; Paclitaxel; Postoperative Complications; Rabbits; Trabeculectomy | 2016 |
Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison.
Topics: Aged; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Forecasting; Humans; Immunosuppressive Agents; Incidence; Japan; Kaplan-Meier Estimate; Male; Paclitaxel; Postoperative Complications; Propensity Score; Retrospective Studies; Sirolimus; ST Elevation Myocardial Infarction; Survival Rate | 2017 |
Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings.
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Survival Rate; Time Factors; Treatment Outcome | 2016 |
[Results of surgical and combined treatment of non-small cell lung cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Treatment Outcome | 2016 |
Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Postoperative Complications; Radiotherapy, Conformal; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
Safety of bailout stenting after paclitaxel-coated balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Patient Safety; Postoperative Complications; Reoperation; Retrospective Studies; Singapore; Stents | 2017 |
Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Female; Germany; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Retrospective Studies; Severity of Illness Index; Survival Rate; Young Adult | 2017 |
Application of paclitaxel as adjuvant treatment for benign cicatricial airway stenosis.
Topics: Adolescent; Adult; Aged; Bronchi; Chemotherapy, Adjuvant; Cicatrix; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Respiratory Insufficiency; Tracheal Stenosis; Tracheotomy | 2016 |
Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Germany; Humans; Incidence; Kaplan-Meier Estimate; Logistic Models; Middle Aged; Multicenter Studies as Topic; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Venous Thromboembolism | 2008 |
Slow-releasing paclitaxel in polytetrafluoroethylene/polylactide-co-glycolide laminate delays adjustment after strabismus surgery in rabbit model.
Topics: Animals; Delayed-Action Preparations; Drug Delivery Systems; Lactic Acid; Oculomotor Muscles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polytetrafluoroethylene; Postoperative Complications; Prospective Studies; Rabbits; Strabismus; Suture Techniques; Tissue Adhesions; Tubulin Modulators; Vision, Binocular | 2008 |
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Netherlands; Paclitaxel; Postoperative Complications; Risk Factors; Sirolimus; Switzerland; Time Factors | 2008 |
[Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population].
Topics: Coronary Artery Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Incidence; Paclitaxel; Postoperative Complications; Risk Assessment; Sirolimus; Thrombosis | 2008 |
Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Child; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Infant; Lung; Lung Neoplasms; Lung Volume Measurements; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Prognosis; Pulmonary Alveoli; Pulmonary Diffusing Capacity; Radiation Injuries; Radiotherapy Dosage; Risk Assessment | 2009 |
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Pulmonary Diffusing Capacity; Radiotherapy Dosage; Retrospective Studies | 2009 |
Impaired wound healing and bilateral mastectomy flap necrosis in a patient with locally advanced breast cancer after neoadjuvant Paclitaxel with bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Humans; Mastectomy; Middle Aged; Necrosis; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications; Skin; Skin Diseases; Surgical Flaps; Wound Healing | 2010 |
The final answer? For the treatment of saphenous vein graft disease, drug-eluting stents vs. bare-metal stents.
Topics: Angioplasty; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Saphenous Vein; Sirolimus; Stents; Treatment Outcome | 2011 |
Two-year outcome of Turkish patients treated with Zotarolimus versus Paclitaxel eluting stents in an unselected population with coronary artery disease in the real world: a prospective non-randomized registry in southern Turkey.
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Patient Selection; Postoperative Complications; Prospective Studies; Random Allocation; Registries; Retrospective Studies; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Turkey | 2011 |
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Registries; Time Factors; Treatment Outcome | 2011 |
[Case of median nerve paralysis after hepatic segmentectomy].
Topics: Antineoplastic Agents, Phytogenic; Hepatectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Median Nerve; Paclitaxel; Paralysis; Postoperative Complications; Posture; Seminoma; Young Adult | 2011 |
Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
Topics: Acute Coronary Syndrome; Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Sirolimus | 2011 |
Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Humans; Injections, Intraperitoneal; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Safety; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2012 |
Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Intestinal Obstruction; Lymph Node Excision; Lymphedema; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms | 2012 |
Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Patient Compliance; Pneumonectomy; Postoperative Complications; Psychosurgery; Retrospective Studies; Thoracic Surgery, Video-Assisted; Thoracotomy; Treatment Outcome | 2011 |
Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Postoperative Complications; Sirolimus; Survival Analysis; Treatment Outcome | 2012 |
The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga.
Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Postoperative Complications; Practice Guidelines as Topic; Sirolimus | 2012 |
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Complications; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Failure; Uterine Neoplasms; Young Adult | 2012 |
Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Sirolimus; Treatment Outcome | 2012 |
Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation.
Topics: Adult; Anastomosis, Surgical; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Cohort Studies; Constriction, Pathologic; Dilatation; Female; Germany; Humans; Liver Transplantation; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prognosis; Prospective Studies; Risk Assessment; Stents; Treatment Outcome | 2012 |
Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up.
Topics: Aged; Angina Pectoris; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prolapse; Prosthesis Failure; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Thrombosis; Tomography, Optical Coherence | 2013 |
Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonectomy; Postoperative Complications; Vinblastine; Vinorelbine | 2002 |
Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line; Graft Survival; Humans; Liver Neoplasms; Liver Transplantation; Paclitaxel; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred BUF; Rats, Inbred Lew; Transplantation, Homologous | 2002 |
Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.
Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; China; Coronary Angiography; Coronary Restenosis; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospitalization; Humans; Immunosuppressive Agents; Italy; Male; Paclitaxel; Postoperative Complications; Proportional Hazards Models; Registries; Retrospective Studies; Saphenous Vein; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2005 |
[Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation].
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Cardiomyopathy, Dilated; Heart Transplantation; Heart-Assist Devices; Humans; Leg; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Thrombosis; Vascular Surgical Procedures | 2005 |
Prolongation of patency of airway bypass stents with use of drug-eluting stents.
Topics: Animals; Bronchi; Dogs; Drug Delivery Systems; Equipment Design; Equipment Failure; Paclitaxel; Postoperative Complications; Pulmonary Emphysema; Stents; Time Factors | 2006 |
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prognosis; Sirolimus; Stents; Time Factors; Treatment Outcome | 2006 |
Recurrent restenosis in a patient with cardiac allograft vasculopathy: after angioplasty and sirolimus, paclitaxel saves the day.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Postoperative Complications; Sirolimus; Stents; Ultrasonography, Interventional | 2006 |
Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pleural Diseases; Pneumonectomy; Pneumonia; Pneumonia, Aspiration; Postoperative Complications; Pulmonary Embolism; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Tract Fistula; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Registries; Risk Factors; Sirolimus; Stents; Taxus; Treatment Outcome | 2006 |
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents.
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Paclitaxel; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Ticlopidine | 2006 |
[Coronary stents and anaesthesia: it is time to have national data].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Coronary Restenosis; Coronary Stenosis; Drug Implants; Female; France; Hematoma; Humans; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Sirolimus; Stents; Surgical Procedures, Operative; Thrombophilia; Thrombosis | 2007 |
One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Reoperation; Research Design; Spain; Stents; Time Factors; Treatment Outcome | 2007 |
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
Topics: Administration, Sublingual; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Postoperative Complications; Stents; Time Factors; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2007 |
[Anesthetic management for scheduled peritonectomy and hyperthermic intraperitoneal chemotherapy in 20 patients].
Topics: Adult; Aged; Analgesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intravenous; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Colloids; Combined Modality Therapy; Crystalloid Solutions; Diuretics; Erythrocyte Transfusion; Female; Fever; Fluid Therapy; Fluorouracil; Humans; Hyperthermia, Induced; Hypotension; Intraoperative Complications; Isotonic Solutions; Male; Middle Aged; Mitomycin; Monitoring, Intraoperative; Paclitaxel; Peritoneal Neoplasms; Peritoneum; Plasma; Postoperative Complications; Prospective Studies; Vasoconstrictor Agents | 2006 |
Late thrombosis of a drug-eluting stent presenting in the perioperative period.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Male; Paclitaxel; Postoperative Complications; Stents | 2007 |
Clinical follow-up of paclitaxel-eluting (TAXUS) stents for the treatment of saphenous vein graft disease.
Topics: Aged; Aged, 80 and over; Databases, Factual; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; New South Wales; Paclitaxel; Postoperative Complications; Prospective Studies; Saphenous Vein; Stents; Survival Analysis; Treatment Outcome | 2007 |
Clinical application of airway bypass with paclitaxel-eluting stents: early results.
Topics: Aged; Aged, 80 and over; Bronchoscopy; Drug Delivery Systems; Equipment Design; Female; Fiber Optic Technology; Humans; Male; Middle Aged; Paclitaxel; Patient Selection; Postoperative Complications; Pulmonary Emphysema; Respiratory Function Tests; Retrospective Studies; Stents; Surveys and Questionnaires; Treatment Outcome | 2007 |
Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Coated Materials, Biocompatible; Female; Follow-Up Studies; Humans; Incidence; Male; Metals; Middle Aged; Paclitaxel; Pilot Projects; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis Implantation; Stents; Survival Rate; Treatment Outcome | 2007 |
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Medical Records; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate | 2008 |
Late incomplete stent apposition after drug-eluting stent implantation: a true risk factor or "an innocent bystander"?
Topics: Coronary Thrombosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Postoperative Complications; Prosthesis Failure; Risk Factors; Sirolimus; Time Factors; Tubulin Modulators; Ultrasonography, Interventional | 2008 |
Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.
Topics: Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Intraoperative Care; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Pleura; Pleural Neoplasms; Pneumonectomy; Postoperative Complications; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 1999 |
Preoperative paclitaxel and radiotherapy for locally advanced breast cancer: surgical aspects.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Feasibility Studies; Female; Humans; Mastectomy, Modified Radical; Middle Aged; Paclitaxel; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 2000 |
Paclitaxel-induced stomal neuropathy: a unique cause of pain in a patient with ileal conduit.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Humans; Ileum; Male; Middle Aged; Neuralgia; Paclitaxel; Peripheral Nervous System Diseases; Postoperative Complications; Surgical Stomas; Urinary Bladder Neoplasms; Urinary Diversion | 2000 |
Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonectomy; Postoperative Complications | 2001 |
[Cardiac conduction abnormalities after neoadjuvant chemotherapy with doxorubicin and docetaxel for primary breast carcinoma: a case report].
Topics: Aged; Anesthesia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin; Female; Heart Block; Humans; Intraoperative Complications; Mastectomy, Segmental; Paclitaxel; Postoperative Complications; Taxoids | 2001 |
Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions.
Topics: Animals; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Hyaluronic Acid; Injections, Intraperitoneal; Paclitaxel; Postoperative Complications; Rats; Rats, Sprague-Dawley; Tissue Adhesions | 2002 |
In vitro release of hydrophobic drugs from polyanhydride disks.
Topics: Alkaloids; Cell Division; Cells, Cultured; Decanoic Acids; Delayed-Action Preparations; Dicarboxylic Acids; Drug Implants; Etoposide; Fibroblasts; Floxuridine; Fluorouracil; Glaucoma; Humans; Mercaptopurine; Paclitaxel; Polymers; Postoperative Complications; Vincristine | 1991 |